New Sickle Cell Therapies Will Be Out of Reach Where They Are Needed Most

Health
By Rebecca Robbins and Stephanie Nolen from NYT Health https://ift.tt/uZ3vhKH
via IFTTT Sickle Cell Anemia, Genetic Engineering, Blood, Genetics and Heredity, Income Inequality, Bone Marrow, Drugs (Pharmaceuticals), Therapy and Rehabilitation, Developing Countries, Crispr (DNA), Transplants, Stem Cells, your-feed-science, your-feed-healthcare There is no clear path for African patients to get access to the treatments, which have multimillion-dollar price tags and are highly complex to manufacture and deliver.

Comments

Post a Comment

Popular posts from this blog

F.D.A. Poised to Restrict Access to Covid Vaccines

Image
Health By Christina Jewett and Apoorva Mandavilli from NYT Health https://ift.tt/VHvAQN8 via IFTTT Vaccination and Immunization, Coronavirus (2019-nCoV), Regulation and Deregulation of Industry, Rumors and Misinformation, Clinical Trials, Medicine and Health Agency leaders said there was evidence to justify approval only for older people and those with medical conditions. Many others may not be able to get the shots.
Read more

U.S. Will No Longer Recommend Covid Shots for Children and Pregnant Women

Image
Health By Apoorva Mandavilli and Christina Jewett from NYT Health https://ift.tt/lefLSPp via IFTTT Vaccination and Immunization, Children and Childhood, United States Politics and Government, Regulation and Deregulation of Industry, Babies and Infants, Pregnancy and Childbirth, Coronavirus (2019-nCoV) Health Secretary Robert F. Kennedy Jr. announced that the vaccine would not be included as part of the immunization schedule for healthy children.
Read more